226 related articles for article (PubMed ID: 25079212)
1. Regulation of osteoclastogenesis by integrated signals from toll-like receptors.
Krisher T; Bar-Shavit Z
J Cell Biochem; 2014 Dec; 115(12):2146-54. PubMed ID: 25079212
[TBL] [Abstract][Full Text] [Related]
2. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
[TBL] [Abstract][Full Text] [Related]
3. Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides.
Amcheslavsky A; Bar-Shavit Z
J Cell Physiol; 2006 Apr; 207(1):244-50. PubMed ID: 16402377
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide-induced osteoclastogenesis in Src homology 2-domain phosphatase-1-deficient viable motheaten mice.
Hayashi S; Tsuneto M; Yamada T; Nose M; Yoshino M; Shultz LD; Yamazaki H
Endocrinology; 2004 Jun; 145(6):2721-9. PubMed ID: 14988381
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 9 ligand blocks osteoclast differentiation through induction of phosphatase.
Amcheslavsky A; Bar-Shavit Z
J Bone Miner Res; 2007 Aug; 22(8):1301-10. PubMed ID: 17488193
[TBL] [Abstract][Full Text] [Related]
6. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.
Hayashi S; Yamada T; Tsuneto M; Yamane T; Takahashi M; Shultz LD; Yamazaki H
J Immunol; 2003 Nov; 171(10):5130-9. PubMed ID: 14607912
[TBL] [Abstract][Full Text] [Related]
7. CpG oligodeoxynucleotides modulate the osteoclastogenic activity of osteoblasts via Toll-like receptor 9.
Zou W; Amcheslavsky A; Bar-Shavit Z
J Biol Chem; 2003 May; 278(19):16732-40. PubMed ID: 12611893
[TBL] [Abstract][Full Text] [Related]
8. Dual modulation of osteoclast differentiation by lipopolysaccharide.
Zou W; Bar-Shavit Z
J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
[TBL] [Abstract][Full Text] [Related]
9. CpG oligonucleotides: novel regulators of osteoclast differentiation.
Zou W; Schwartz H; Endres S; Hartmann G; Bar-Shavit Z
FASEB J; 2002 Mar; 16(3):274-82. PubMed ID: 11874977
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 9 regulates tumor necrosis factor-alpha expression by different mechanisms. Implications for osteoclastogenesis.
Amcheslavsky A; Zou W; Bar-Shavit Z
J Biol Chem; 2004 Dec; 279(52):54039-45. PubMed ID: 15485822
[TBL] [Abstract][Full Text] [Related]
11. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
Arsenault RJ; Kogut MH; He H
Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
[TBL] [Abstract][Full Text] [Related]
12. Synergy of CpG oligodeoxynucleotide and double-stranded RNA (poly I:C) on nitric oxide induction in chicken peripheral blood monocytes.
He H; Genovese KJ; Nisbet DJ; Kogut MH
Mol Immunol; 2007 May; 44(12):3234-42. PubMed ID: 17339052
[TBL] [Abstract][Full Text] [Related]
13. Stimulation by toll-like receptors inhibits osteoclast differentiation.
Takami M; Kim N; Rho J; Choi Y
J Immunol; 2002 Aug; 169(3):1516-23. PubMed ID: 12133979
[TBL] [Abstract][Full Text] [Related]
14. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
Grcević D; Lukić IK; Kovacić N; Ivcević S; Katavić V; Marusić A
Clin Exp Immunol; 2006 Oct; 146(1):146-58. PubMed ID: 16968409
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling.
AlQranei MS; Senbanjo LT; Aljohani H; Hamza T; Chellaiah MA
BMC Immunol; 2021 Mar; 22(1):23. PubMed ID: 33765924
[TBL] [Abstract][Full Text] [Related]
16. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
17. IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro.
Gorny G; Shaw A; Oursler MJ
Exp Cell Res; 2004 Mar; 294(1):149-58. PubMed ID: 14980510
[TBL] [Abstract][Full Text] [Related]
18. CpG oligodeoxynucleotide and double-stranded RNA synergize to enhance nitric oxide production and mRNA expression of inducible nitric oxide synthase, pro-inflammatory cytokines and chemokines in chicken monocytes.
He H; MacKinnon KM; Genovese KJ; Kogut MH
Innate Immun; 2011 Apr; 17(2):137-44. PubMed ID: 20083501
[TBL] [Abstract][Full Text] [Related]
19. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity.
Whitmore MM; DeVeer MJ; Edling A; Oates RK; Simons B; Lindner D; Williams BR
Cancer Res; 2004 Aug; 64(16):5850-60. PubMed ID: 15313929
[TBL] [Abstract][Full Text] [Related]
20. The phosphatidylinositol 3-kinase-mediated production of interferon-beta is critical for the lipopolysaccharide inhibition of osteoclastogenesis.
Lee Y; Huang H; Kim HJ; Park CK; Kim HH
Life Sci; 2008 Aug; 83(9-10):369-76. PubMed ID: 18675826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]